Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis
Theodoros D. Karamitsos(John Radcliffe Hospital), James Moon(Virginia Mason Medical Center), Vanessa M. Ferreira(John Radcliffe Hospital), Philip N. Hawkins(The Royal Free Hospital), Ntobeko Ntusi(John Radcliffe Hospital), Marianna Fontana(Johnson & Johnson (United States)), Saul Myerson(John Radcliffe Hospital), Matthew D. Robson(John Radcliffe Hospital), Carol Whelan(Boston University), Stefan Neubauer(University of Oxford), Stefan K. Piechnik(University of Oxford), Sanjay M Banypersad(University College Hospital at Westmoreland Street)
Cited by 664
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k